1. Genetic and functional analyses implicate microRNA 499A in bipolar disorder development
- Author
-
Aileen Tielke, Helena Martins, Michael A. Pelzl, Anna Maaser-Hecker, Friederike S. David, Céline S. Reinbold, Fabian Streit, Lea Sirignano, Markus Schwarz, Helmut Vedder, Jutta Kammerer-Ciernioch, Margot Albus, Margitta Borrmann-Hassenbach, Martin Hautzinger, Karola Hünten, Franziska Degenhardt, Sascha B. Fischer, Eva C. Beins, Stefan Herms, Per Hoffmann, Thomas G. Schulze, Stephanie H. Witt, Marcella Rietschel, Sven Cichon, Markus M. Nöthen, Gerhard Schratt, and Andreas J. Forstner
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Abstract Bipolar disorder (BD) is a complex mood disorder with a strong genetic component. Recent studies suggest that microRNAs contribute to psychiatric disorder development. In BD, specific candidate microRNAs have been implicated, in particular miR-137, miR-499a, miR-708, miR-1908 and miR-2113. The aim of the present study was to determine the contribution of these five microRNAs to BD development. For this purpose, we performed: (i) gene-based tests of the five microRNA coding genes, using data from a large genome-wide association study of BD; (ii) gene-set analyses of predicted, brain-expressed target genes of the five microRNAs; (iii) resequencing of the five microRNA coding genes in 960 BD patients and 960 controls and (iv) in silico and functional studies for selected variants. Gene-based tests revealed a significant association with BD for MIR499A, MIR708, MIR1908 and MIR2113. Gene-set analyses revealed a significant enrichment of BD associations in the brain-expressed target genes of miR-137 and miR-499a-5p. Resequencing identified 32 distinct rare variants (minor allele frequency
- Published
- 2022
- Full Text
- View/download PDF